Inflo Health expands platform with AI-driven cardiology orchestration suite to close diagnostic-to-care gap
Published: 10 Mar 2026
Author: Precedence Research
Inflo Health has introduced a new cardiology suite within its enterprise platform aimed at addressing care coordination gaps in some of the most common and expensive cardiovascular conditions. The newly launched solution focuses on managing abdominal aortic aneurysm (AAA), heart failure, and coronary artery calcification (CAC), offering healthcare systems a structured approach to move patients from diagnostic detection to timely clinical care. The expansion marks a major development for the company as it evolves its platform into a comprehensive care orchestration layer capable of managing diagnostic insights across multiple specialties.
Healthcare providers are rapidly adopting artificial intelligence–based detection tools, particularly in medical imaging. However, the surge in diagnostic insights has created a new challenge for hospitals: ensuring that identified abnormalities translate into actionable care plans. In cardiology, this issue is particularly pronounced because findings such as calcification scores or aneurysm indicators are frequently documented but may not always trigger consistent follow-up care. Inflo Health’s latest platform upgrade is designed to address this “last-mile” gap by connecting diagnostic outputs with structured care pathways and coordinated patient management.
According to Angela Adams, the company aims to bridge the divide between diagnostic discovery and treatment execution. Many healthcare organizations struggle to guide patients through the next step in their care journey after a condition is detected, especially without overwhelming already strained clinical teams. The Inflo platform aggregates insights from AI detection tools and traditional diagnostic systems, then integrates them with electronic health records to guide providers and patients through defined care pathways. By doing so, the platform aims to reduce operational complexity while improving patient engagement and clinical outcomes.
Healthcare systems are increasingly recognizing the need for an orchestration layer capable of managing large volumes of diagnostic information. As AI algorithms continue to generate new clinical insights, hospitals require scalable infrastructure that ensures those findings lead to timely interventions. Inflo Health’s platform is designed to manage this process by assigning ownership, establishing timelines for follow-up, and enabling escalation when required. This structure helps ensure that patients are not lost between detection and treatment.
Industry experts also highlight the importance of such coordination tools in cardiology. Mahesh Amin noted that cardiology imaging produces a constant stream of clinically significant findings. While documenting those findings is relatively straightforward, the challenge lies in ensuring that the next clinical step occurs reliably. By collaborating with Inflo Health, healthcare providers can implement structured systems that ensure patients understand and complete their recommended care plans.
The new cardiology suite focuses on three primary clinical pathways. AAA management emphasizes surveillance and timely escalation when necessary. Heart failure workflows coordinate imaging, cardiology consultation, and ongoing monitoring. Meanwhile, CAC management converts incidental imaging findings into preventive cardiovascular care programs that engage patients earlier in the disease progression process. Together, these pathways aim to improve both patient outcomes and operational efficiency.
Beyond adding another specialty-specific tool, Inflo Health is positioning its technology as part of a broader category known as diagnostic care orchestration. The system functions as a detection-agnostic layer, meaning it can process findings from multiple imaging modalities and AI systems while ensuring that each result is linked to a defined care pathway. This capability allows healthcare organizations to maximize the value of their diagnostic investments.
According to Precedence Research, the global cardiorespiratory assessment units market size is projected to grow significantly over the coming years, driven by rising cardiovascular disease prevalence, expanding diagnostic infrastructure, and increasing adoption of advanced monitoring technologies in hospitals and specialty clinics. The market is expected to expand from USD 1.56 billion in 2026 to approximately USD 3.00 billion by 2035, growing at a CAGR of 7.55% during the forecast period. Growing emphasis on early disease detection and integrated patient management systems is expected to further support demand for advanced cardiology diagnostic and care coordination solutions.
Inflo Health’s cardiology expansion builds on earlier successes with its diagnostic orchestration platform. Healthcare providers using the technology have reported measurable improvements in care follow-up rates and operational performance. For example, one healthcare network reported a financial return of approximately USD 1.7 million within six months of adopting the platform, while another hospital system achieved a significant increase in follow-up completion rates for incidental imaging findings.
As healthcare organizations continue to invest heavily in AI diagnostics and advanced imaging technologies, the ability to transform diagnostic insights into coordinated care pathways will become increasingly important. By expanding its platform into cardiology, Inflo Health aims to create a scalable infrastructure that ensures clinical findings lead to timely intervention, improved governance, and stronger patient outcomes across the healthcare ecosystem.